Who founded Kymera Therapeutics?

Kymera Therapeutics was founded by Nello Mainolfi, Bruce Booth in 2016.

Who are Kymera Therapeutics's investors?

Kymera Therapeutics's investors include Atlas Venture, Avoro Capital Advisors, Bain Capital Life Sciences, Bessemer Venture Partners, Hatteras Venture Partners, MRL Ventures Fund, Nextech Invest, Pfizer Venture Investments and 4 more.

Kymera Therapeutics

NASDAQ: KYMRUnicorn · $2.3B

Founded 2016 · Incorporated in Delaware · 303 employees on LinkedIn · 12 known investors

Find your way into Kymera Therapeutics

338 people in our graph share verified history with the Kymera Therapeutics team — schools, employers, funds. One of them is your warm intro.

Giovanni Mariggiunlockedknows Nello Mainolfi · together at Imperial College London (overlapped)

×2knows the team · via Imperial College London

knows the team · via Kymera Therapeutics

×3knows the team · via Atlas Venture

knows the team · via The Scripps Research Institute

×4knows the team · via Queen Mary University of London

Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins. The company focuses on advancing small molecule therapies designed to address critical health problems across multiple disease areas.

Biotech Deep Tech Healthtech

Founders & leadership

Kymera Therapeutics was founded in 2016 by Nello Mainolfi and Bruce Booth.

Nello Mainolfi inFounder, President and Chief Executive OfficerFounder of Kymera Therapeutics, a clinical-stage biotech developing targeted protein degradation medicines, where he works on advancing a new class of degrader therapies. He has held science, leadership, and business roles across large pharma and biotech, with experience in company creation, scaling, strategic partnerships, and private and public offerings.

Bruce Booth in 𝕏ChairPartner at Atlas Venture

Investors · 12

Atlas VentureCambridge · $500K – $1M

Avoro Capital AdvisorsNew York

Bain Capital Life SciencesBoston

Bessemer Venture PartnersRedwood City · $5M – $100M

Hatteras Venture PartnersResearch Triangle · $500K – $4M

MRL Ventures FundCambridge · $25M

Nextech InvestZurich · $648K – $3.2M

Pfizer Venture Investments$5M – $20M

Sanofi VenturesCambridge · $5M

Solasta VenturesBoston

Biotechnology Value FundreportedSan Francisco

REDMILEreportedSan Francisco

Valuation · disclosed

Disclosed events

$2.3Bvaluation at IPOJul 2021 · $47.00/share · 424B4

filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Founder mafia

2 people who came through Kymera Therapeutics went on to found or lead other companies.

Wei LiBoard MemberFounded Quantxbio +1 John MaraganoreBoard MemberFounded Alnylam

Competitors · 2

by search overlap

Bioworld63 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Seeking Alpha47 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Companies competing with Kymera Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Kymera Therapeutics do?: Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins. The company focuses on advancing small molecule therapies designed to address critical health problems across multiple disease areas.
Who founded Kymera Therapeutics?: Kymera Therapeutics was founded by Nello Mainolfi, Bruce Booth in 2016.
Who are Kymera Therapeutics's investors?: Kymera Therapeutics's investors include Atlas Venture, Avoro Capital Advisors, Bain Capital Life Sciences, Bessemer Venture Partners, Hatteras Venture Partners, MRL Ventures Fund, Nextech Invest, Pfizer Venture Investments and 4 more.